StockData
Oculis Holding AG logo

Oculis Holding AG (OCS) stock

OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026Score 1/30
$7.51−0.12 (-1.57%)

Close on Nov 17, 2026Market cap $451.27MP/E –Yield –

Oculis operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -CHF 66.30M. The highest annual figure on record is -CHF 12.03M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CHF 66.30M–
FY2024Dec 31, 2024-CHF 48.92M–
FY2023Dec 31, 2023-CHF 55.04M–
FY2022Dec 31, 2022-CHF 25.07M–
FY2021Dec 31, 2021-CHF 13.83M–
FY2020Dec 31, 2020-CHF 12.03M–

More Oculis figures

See a number that looks wrong?